Lazulide

Losartan potassium, the active ingredient in Lazulide, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It is used to lower blood pressure and protect the kidneys in patients with hypertension, heart failure, or diabetic nephropathy. It works by blocking the effects of angiotensin II, a hormone that narrows blood vessels, thereby helping to relax vessels and reduce strain on the heart.

GNH USA supplies Lazulide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lazulide (losartan potassium) acts on the renin‑angiotensin‑aldosterone system to manage several cardiovascular and renal conditions. - Hypertension: reduces systolic and diastolic blood pressure, lowering risk of cardiovascular events. - Heart failure: improves symptoms and reduces hospitalizations by decreasing afterload. - Diabetic nephropathy: slows progression of kidney damage by lowering intraglomerular pressure.

Like other ARBs, losartan may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: light‑headed sensation, especially after standing. - Headache: mild to moderate pain in the head. - Fatigue: feeling unusually tired or weak. - Nasal congestion: blocked or runny nose. - Cough: dry irritation of the throat. - Back pain: discomfort in the lower spine.

Serious or Rare Side Effects: - Hyperkalemia: elevated blood potassium that can affect heart rhythm. - Acute kidney injury: sudden decline in renal function requiring monitoring. - Angio‑edema: rapid swelling of the face, lips, tongue or throat, potentially compromising airway. - Liver enzyme elevation: increased transaminases indicating hepatic stress.

Before prescribing Lazulide, clinicians should evaluate patient history and monitor laboratory parameters. - Renal function: assess creatinine and eGFR before initiation and periodically. - Electrolytes: monitor serum potassium, especially in patients on potassium‑sparing diuretics. - Volume status: avoid use in patients with severe dehydration or volume depletion. - Concomitant NSAIDs: use cautiously as they may increase risk of renal impairment. - Pregnancy: avoid during the second and third trimesters due to fetal toxicity risk. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Losartan can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Potassium supplements or potassium‑sparing diuretics: may cause dangerous hyperkalemia. - Aliskiren (in diabetic patients): combined use can increase renal dysfunction and hyperkalemia risk. - Dual ARB/ACE inhibitor therapy: heightens risk of hypotension, renal impairment, and hyperkalemia.

Moderate Interactions (Monitor Closely): - NSAIDs (ibuprofen, naproxen): can reduce antihypertensive effect and impair renal function. - Lithium: may increase lithium levels, risking toxicity. - Cyclosporine or tacrolimus: may raise serum creatinine and potassium.